Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review

An intranasal formulation of midazolam, Nayzilam, has been FDA-approved to treat intermittent, stereotypic episodes of frequent seizure activity. Nayzilam is easy to administer and can quickly treat seizures that occur outside of the hospital. The intra-nasal route of administration allows non-medic...

Full description

Saved in:
Bibliographic Details
Main Authors: Elyse M. Cornett, Meskerem A. Nemomsa, Bailey Turbeville, Matthew A. Busby, Jessica S. Kaye, Aaron J. Kaye, JooHee Choi, Giovanni F. Ramírez, Giustino Varrassi, Adam M. Kaye, Alan D. Kaye, James Wilson, Latha Ganti
Format: Article
Language:English
Published: Open Medical Publishing 2022-10-01
Series:Health Psychology Research
Online Access:https://doi.org/10.52965/001c.38536
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825139351479123968
author Elyse M. Cornett
Meskerem A. Nemomsa
Bailey Turbeville
Matthew A. Busby
Jessica S. Kaye
Aaron J. Kaye
JooHee Choi
Giovanni F. Ramírez
Giustino Varrassi
Adam M. Kaye
Alan D. Kaye
James Wilson
Latha Ganti
author_facet Elyse M. Cornett
Meskerem A. Nemomsa
Bailey Turbeville
Matthew A. Busby
Jessica S. Kaye
Aaron J. Kaye
JooHee Choi
Giovanni F. Ramírez
Giustino Varrassi
Adam M. Kaye
Alan D. Kaye
James Wilson
Latha Ganti
author_sort Elyse M. Cornett
collection DOAJ
description An intranasal formulation of midazolam, Nayzilam, has been FDA-approved to treat intermittent, stereotypic episodes of frequent seizure activity. Nayzilam is easy to administer and can quickly treat seizures that occur outside of the hospital. The intra-nasal route of administration allows non-medical personal to administer the drug which makes it more accessible and user-friendly in the event of a seizure. Many studies have indicated quick cessation of seizures with Nayzilam compared to rectal diazepam, which has been the standard of care treatment. Nayzilam has been proven to be safe and effective for acute seizures in children, deeming it a revolutionary alternative in times where intravenous administration is not possible.
format Article
id doaj-art-c9e47bdb96dd47ce9ec6a91c04faa9e9
institution Kabale University
issn 2420-8124
language English
publishDate 2022-10-01
publisher Open Medical Publishing
record_format Article
series Health Psychology Research
spelling doaj-art-c9e47bdb96dd47ce9ec6a91c04faa9e92025-02-11T20:30:40ZengOpen Medical PublishingHealth Psychology Research2420-81242022-10-01105Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive reviewElyse M. CornettMeskerem A. NemomsaBailey TurbevilleMatthew A. BusbyJessica S. KayeAaron J. KayeJooHee ChoiGiovanni F. RamírezGiustino VarrassiAdam M. KayeAlan D. KayeJames WilsonLatha GantiAn intranasal formulation of midazolam, Nayzilam, has been FDA-approved to treat intermittent, stereotypic episodes of frequent seizure activity. Nayzilam is easy to administer and can quickly treat seizures that occur outside of the hospital. The intra-nasal route of administration allows non-medical personal to administer the drug which makes it more accessible and user-friendly in the event of a seizure. Many studies have indicated quick cessation of seizures with Nayzilam compared to rectal diazepam, which has been the standard of care treatment. Nayzilam has been proven to be safe and effective for acute seizures in children, deeming it a revolutionary alternative in times where intravenous administration is not possible.https://doi.org/10.52965/001c.38536
spellingShingle Elyse M. Cornett
Meskerem A. Nemomsa
Bailey Turbeville
Matthew A. Busby
Jessica S. Kaye
Aaron J. Kaye
JooHee Choi
Giovanni F. Ramírez
Giustino Varrassi
Adam M. Kaye
Alan D. Kaye
James Wilson
Latha Ganti
Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review
Health Psychology Research
title Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review
title_full Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review
title_fullStr Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review
title_full_unstemmed Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review
title_short Midazolam nasal spray to treat intermittent, stereotypic episodes of frequent seizure activity: pharmacology and clinical role, a comprehensive review
title_sort midazolam nasal spray to treat intermittent stereotypic episodes of frequent seizure activity pharmacology and clinical role a comprehensive review
url https://doi.org/10.52965/001c.38536
work_keys_str_mv AT elysemcornett midazolamnasalspraytotreatintermittentstereotypicepisodesoffrequentseizureactivitypharmacologyandclinicalroleacomprehensivereview
AT meskeremanemomsa midazolamnasalspraytotreatintermittentstereotypicepisodesoffrequentseizureactivitypharmacologyandclinicalroleacomprehensivereview
AT baileyturbeville midazolamnasalspraytotreatintermittentstereotypicepisodesoffrequentseizureactivitypharmacologyandclinicalroleacomprehensivereview
AT matthewabusby midazolamnasalspraytotreatintermittentstereotypicepisodesoffrequentseizureactivitypharmacologyandclinicalroleacomprehensivereview
AT jessicaskaye midazolamnasalspraytotreatintermittentstereotypicepisodesoffrequentseizureactivitypharmacologyandclinicalroleacomprehensivereview
AT aaronjkaye midazolamnasalspraytotreatintermittentstereotypicepisodesoffrequentseizureactivitypharmacologyandclinicalroleacomprehensivereview
AT jooheechoi midazolamnasalspraytotreatintermittentstereotypicepisodesoffrequentseizureactivitypharmacologyandclinicalroleacomprehensivereview
AT giovanniframirez midazolamnasalspraytotreatintermittentstereotypicepisodesoffrequentseizureactivitypharmacologyandclinicalroleacomprehensivereview
AT giustinovarrassi midazolamnasalspraytotreatintermittentstereotypicepisodesoffrequentseizureactivitypharmacologyandclinicalroleacomprehensivereview
AT adammkaye midazolamnasalspraytotreatintermittentstereotypicepisodesoffrequentseizureactivitypharmacologyandclinicalroleacomprehensivereview
AT alandkaye midazolamnasalspraytotreatintermittentstereotypicepisodesoffrequentseizureactivitypharmacologyandclinicalroleacomprehensivereview
AT jameswilson midazolamnasalspraytotreatintermittentstereotypicepisodesoffrequentseizureactivitypharmacologyandclinicalroleacomprehensivereview
AT lathaganti midazolamnasalspraytotreatintermittentstereotypicepisodesoffrequentseizureactivitypharmacologyandclinicalroleacomprehensivereview